# A Study of LY3039478 in Participants With Advanced Cancer

> **NCT01695005** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 247 (actual)

## Conditions studied

- Neoplasms
- Neoplasm Metastasis
- Lymphoma

## Interventions

- **DRUG:** LY3039478
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01695005
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2018-06-26
- **Final completion:** 2018-06-26
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01695005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01695005, "A Study of LY3039478 in Participants With Advanced Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01695005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*